The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Castration resistant prostate cancer patients treated with enzalutamide may develop resistance to the drug. Here, the authors report that monoamine oxidase-A expression is increased in these resistant tumors and that the antidepressants phenelzine/clorgyline can reverse such resistance to further su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keliang Wang, Jie Luo, Shuyuan Yeh, Bosen You, Jialin Meng, Philip Chang, Yuanjie Niu, Gonghui Li, Changxue Lu, Yezi Zhu, Emmanuel S. Antonarakis, Jun Luo, Chi-Ping Huang, Wanhai Xu, Chawnshang Chang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/e9d6def113e84a60bc881fcbffc3cdfb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e9d6def113e84a60bc881fcbffc3cdfb
record_format dspace
spelling oai:doaj.org-article:e9d6def113e84a60bc881fcbffc3cdfb2021-12-02T18:24:58ZThe MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer10.1038/s41467-020-15396-52041-1723https://doaj.org/article/e9d6def113e84a60bc881fcbffc3cdfb2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15396-5https://doaj.org/toc/2041-1723Castration resistant prostate cancer patients treated with enzalutamide may develop resistance to the drug. Here, the authors report that monoamine oxidase-A expression is increased in these resistant tumors and that the antidepressants phenelzine/clorgyline can reverse such resistance to further suppress tumor growthKeliang WangJie LuoShuyuan YehBosen YouJialin MengPhilip ChangYuanjie NiuGonghui LiChangxue LuYezi ZhuEmmanuel S. AntonarakisJun LuoChi-Ping HuangWanhai XuChawnshang ChangNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Keliang Wang
Jie Luo
Shuyuan Yeh
Bosen You
Jialin Meng
Philip Chang
Yuanjie Niu
Gonghui Li
Changxue Lu
Yezi Zhu
Emmanuel S. Antonarakis
Jun Luo
Chi-Ping Huang
Wanhai Xu
Chawnshang Chang
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
description Castration resistant prostate cancer patients treated with enzalutamide may develop resistance to the drug. Here, the authors report that monoamine oxidase-A expression is increased in these resistant tumors and that the antidepressants phenelzine/clorgyline can reverse such resistance to further suppress tumor growth
format article
author Keliang Wang
Jie Luo
Shuyuan Yeh
Bosen You
Jialin Meng
Philip Chang
Yuanjie Niu
Gonghui Li
Changxue Lu
Yezi Zhu
Emmanuel S. Antonarakis
Jun Luo
Chi-Ping Huang
Wanhai Xu
Chawnshang Chang
author_facet Keliang Wang
Jie Luo
Shuyuan Yeh
Bosen You
Jialin Meng
Philip Chang
Yuanjie Niu
Gonghui Li
Changxue Lu
Yezi Zhu
Emmanuel S. Antonarakis
Jun Luo
Chi-Ping Huang
Wanhai Xu
Chawnshang Chang
author_sort Keliang Wang
title The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
title_short The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
title_full The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
title_fullStr The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
title_full_unstemmed The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
title_sort mao inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e9d6def113e84a60bc881fcbffc3cdfb
work_keys_str_mv AT keliangwang themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT jieluo themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT shuyuanyeh themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT bosenyou themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT jialinmeng themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT philipchang themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT yuanjieniu themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT gonghuili themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT changxuelu themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT yezizhu themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT emmanuelsantonarakis themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT junluo themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT chipinghuang themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT wanhaixu themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT chawnshangchang themaoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT keliangwang maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT jieluo maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT shuyuanyeh maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT bosenyou maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT jialinmeng maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT philipchang maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT yuanjieniu maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT gonghuili maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT changxuelu maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT yezizhu maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT emmanuelsantonarakis maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT junluo maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT chipinghuang maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT wanhaixu maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
AT chawnshangchang maoinhibitorsphenelzineandclorgylinerevertenzalutamideresistanceincastrationresistantprostatecancer
_version_ 1718378071080304640